NCT04382183

Brief Summary

Low-carb ketogenic diets have become extremely popular because of large weight loss in the short-term. Yet their potential benefits in preventing long-term weight regain have not been assessed in large scale studies. The aim of this study is to determine the effect of a low-carbohydrate (CHO) ketogenic diet, compared with an isocaloric balanced diet, on the maintenance of weight loss. The secondary aim is to investigate the impact of both diets on appetite. Adults with obesity (30\<BMI\<40 kg/m2), will first undergo 4 weeks of a very-low energy diet aimed at inducing 5-10% weight loss and then will be randomized to two different weight maintenance diets for 1 year. One will be a low-CHO ketogenic diet (50 g CHO/day) plant-based (e.g. with less animal protein and more plant-based), and the other a diet following the Norwegian Health Directorate recommendations. Only conventional foods will be used in both diets.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 11, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

August 3, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2021

Completed
Last Updated

April 29, 2022

Status Verified

April 1, 2022

Enrollment Period

1.4 years

First QC Date

April 28, 2020

Last Update Submit

April 28, 2022

Conditions

Keywords

Diet, KetogenicWeight LossBody Weight

Outcome Measures

Primary Outcomes (1)

  • Body weight regain

    Body weight will be measured at baseline, at week 5, at 6 months, and at 1 year

    Body weight changes at 1-year intervention

Secondary Outcomes (2)

  • Fasting lipid profile

    Lipid profile changes at 1-year intervention

  • Bone mineral density

    Bone mineral density changes at 1-year intervention

Study Arms (2)

Ketogenic weight loss maintenance diet

EXPERIMENTAL

The ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.

Behavioral: Ketogenic weight loss maintenance diet

Isocaloric balanced weight loss maintenance diet

EXPERIMENTAL

The isocaloric balanced weight loss maintenance group will undergo in a diet following the standard Norwegian Health Directorate recommendations for 1 year.

Behavioral: Isocaloric balanced weight loss maintenance diet

Interventions

The ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.

Ketogenic weight loss maintenance diet

The isocaloric balanced weight loss maintenance group will undergo in a diet following the recommendations from the Norwegian Health Directorate for 1 year.

Isocaloric balanced weight loss maintenance diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • weight stable over the last three months (\<2 kg)
  • not currently dieting to lose weight
  • inactive lifestyle (less than 150 min of physical activity weekly.
  • Given that some of the variables of interest have been shown to be affected by the phase of menstrual cycle in normally ovulating women, namely appetite and resting metabolic rate, only women taking oral contraceptives, with regular menstrual cycles or post-menopausal will be included in the study

You may not qualify if:

  • pregnancy
  • breast-feeding
  • drug or alcohol abuse within the last two years
  • clinically significant illness including diabetes, gastrointestinal (particularly cholelithiasis), kidney (GFR \<60) or liver disease, osteoporosis (T-score \<-2.5) and osteopenia (T-score \<-1.5)
  • treatment with antiosteoporotic drug
  • depression or other psychological disorders
  • eating disorders
  • milk intolerance
  • current medication known to affect appetite/metabolism or induce weight loss.
  • a planned surgery during the study period
  • participating in another research study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forsyningssenteret at NTNU

Trondheim, Norway

Location

MeSH Terms

Conditions

ObesityWeight LossBody Weight

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Torstein Baade Rø, MD PhD

    NTNU Faculty of Medicine and Health Sciences, IKOM

    STUDY DIRECTOR
  • Birger Henning Endreseth, Professor

    St. Olvas Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2020

First Posted

May 11, 2020

Study Start

August 3, 2020

Primary Completion

December 10, 2021

Study Completion

December 10, 2021

Last Updated

April 29, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations